• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

2013 Predictions













Does anyone really know if we're closing Jan. 2014?

Here's an answer to your question from a Bostwick Labs post:
CSI is going to die. Better be heading back to school. It's going to be a bloodbath next year. Many will not survive. LIke roaches, quest and labcorp and large hospital labs will thrive.
 












From the NEO board:

Had a client last week tell me that now CSI is trying to offer tech FISH. Great timing guys, push that tech product hard for the next six weeks and then you can use that million dollar equipment as a paperweight. What a joke!